PUBLISHER: IMARC | PRODUCT CODE: 1390637
PUBLISHER: IMARC | PRODUCT CODE: 1390637
The global topical pain relief market size reached US$ 9.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 14.2 Billion by 2028, exhibiting a growth rate (CAGR) of 6.20% during 2022-2028.
Topical preparations for pain relief are generally available in the form of liquids, gels, powders, creams, semisolids, emulsions, patches, foams, or aerosols. They are applied on or around the site of pain or inflammation in case of strains, sprains, tendinopathy, muscle aches, and osteoarthritis. They gradually enter the bloodstream and keep the blood levels relatively constant for a certain period. At present, pharmaceutical companies around the world are focusing on developing new routes of drug administration for providing personalized treatments to patients without decreasing the efficacy of topical analgesic or pain-relieving drugs.
The increasing prevalence of chronic pain on account of diabetic neuropathy, arthritis, multiple sclerosis, fibromyalgia, and shingles represents one of the significant factors escalating the demand for topical pain relief medications across the globe. Apart from this, the rising number of individuals participating in sports activities is also positively influencing the sales of topical pain relief medications worldwide. Moreover, the growing number of cancer patients is resulting in the increasing sales of topical pain relievers via e-commerce platforms. Furthermore, leading pharmaceutical companies are introducing topical painkillers or analgesics for managing the pain of cancer patients. They are also focusing on the development of medications that simplify treatment and reduce adverse effects. This is anticipated to expand the applications of topical pain relief medications amongst elderly and pediatric populations, as well as individuals who are intolerant to other routes of administration.
IMARC Group provides an analysis of the key trends in each sub-segment of the global topical pain relief market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on therapeutic class, formulation, type and distribution channel.
Non-Opioids
Opioids
Cream
Gel
Spray
Patch
Others
Prescription Pain Relief
Over the Counter (OTC) Pain Relief
Pharmacy and Drug Stores
Retail Stores
Online Stores
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advacare Pharma, Exzell Pharma Inc., Glaxosmithkline Plc, Johnson & Johnson, Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi S.A., Sun Pharmaceutical Industries Limited and Topical Biomedics Inc.
List of Figures